ATE282634T1 - Chaperonin 10 - Google Patents

Chaperonin 10

Info

Publication number
ATE282634T1
ATE282634T1 AT95902003T AT95902003T ATE282634T1 AT E282634 T1 ATE282634 T1 AT E282634T1 AT 95902003 T AT95902003 T AT 95902003T AT 95902003 T AT95902003 T AT 95902003T AT E282634 T1 ATE282634 T1 AT E282634T1
Authority
AT
Austria
Prior art keywords
seq
antibodies
cpn
cpn10
raised against
Prior art date
Application number
AT95902003T
Other languages
English (en)
Inventor
Halle Morton
Alice Christina Cavanagh
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM8234A external-priority patent/AUPM823494A0/en
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of ATE282634T1 publication Critical patent/ATE282634T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
AT95902003T 1993-11-30 1994-11-30 Chaperonin 10 ATE282634T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM270593 1993-11-30
AUPM8234A AUPM823494A0 (en) 1994-09-16 1994-09-16 Diagnostic and therapeutic uses of chaperonin 10
PCT/AU1994/000740 WO1995015338A1 (en) 1993-11-30 1994-11-30 Chaperonin 10

Publications (1)

Publication Number Publication Date
ATE282634T1 true ATE282634T1 (de) 2004-12-15

Family

ID=25644587

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902003T ATE282634T1 (de) 1993-11-30 1994-11-30 Chaperonin 10

Country Status (11)

Country Link
US (3) US6113899A (de)
EP (2) EP0733071A4 (de)
JP (3) JP3545408B2 (de)
AT (1) ATE282634T1 (de)
AU (2) AU684577B2 (de)
CA (1) CA2177179C (de)
DE (1) DE69434137T2 (de)
ES (1) ES2233938T3 (de)
NZ (2) NZ276672A (de)
PT (1) PT731811E (de)
WO (2) WO1995015339A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU684577B2 (en) * 1993-11-30 1997-12-18 University Of Queensland, The Chaperonin 10
CA2290038A1 (en) * 1997-07-10 1999-01-21 Alan Fersht Chaperone fragments
US6007821A (en) * 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins
US6475490B1 (en) 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
AUPP823999A0 (en) * 1999-01-20 1999-02-11 University Of Queensland, The A treatment
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method
CN100406891C (zh) * 2001-06-27 2008-07-30 詹森药业有限公司 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
GB0226105D0 (en) * 2002-11-08 2002-12-18 St Georges S Entpr Ltd Pain relief agents
MXPA06008082A (es) * 2004-01-16 2007-03-21 Cbio Ltd Modulacion de la secrecion de quimioquina y de citoquina inducible por el receptor similar al de toll por medio de chaperonina 10.
CA2620729A1 (en) 2005-08-31 2007-03-08 Cbio Limited Modified chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
WO2007045046A1 (en) * 2005-10-20 2007-04-26 Cbio Limited Treatment of hypersensitivity
JP2009528297A (ja) * 2006-03-02 2009-08-06 シーバイオ リミテッド 抗原提示細胞の機能の調節による免疫応答の制御
RU2010145972A (ru) 2008-04-11 2012-05-20 СиБАЙО ЛИМИТЕД (AU) МОДИФИЦИРОВАННЫЙ Cpn10 И ПЕРЕДАЧА СИГНАЛА PRR
WO2011041847A1 (en) * 2009-10-09 2011-04-14 Cbio Limited Chaperonin 10 variants
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262119A1 (de) * 1985-03-12 1988-04-06 University Of Queensland Nachweis des frühempfängnisfaktors in säugetieren, reinigung des faktors und herstellung monoklonaler antikörper
AU599021B2 (en) * 1985-03-12 1990-07-12 University Of Queensland, The Method for detecting early pregnancy factor (epf) in mammals,purifying epf and method for producing a monoclonal antibody
EP0345260A4 (de) * 1986-12-22 1990-05-14 Univ Queensland Verfahren zur behandlung von säugetieren mit antikörpern gegen den frühempfangnisfaktor (epf).
AU1086988A (en) * 1986-12-22 1988-07-15 University Of Queensland, The Method of treatment of mammals using antibodies to early pregnancy factor (epf)
AU684577B2 (en) * 1993-11-30 1997-12-18 University Of Queensland, The Chaperonin 10

Also Published As

Publication number Publication date
EP0731811A4 (de) 2003-05-28
US20030175280A1 (en) 2003-09-18
AU1103495A (en) 1995-06-19
JPH09505811A (ja) 1997-06-10
EP0733071A4 (de) 1997-02-26
NZ276672A (en) 1998-01-26
ES2233938T3 (es) 2005-06-16
DE69434137D1 (en) 2004-12-23
JP3986481B2 (ja) 2007-10-03
WO1995015339A1 (en) 1995-06-08
CA2177179A1 (en) 1995-06-08
US7358329B2 (en) 2008-04-15
NZ276670A (en) 1998-01-26
JPH09506431A (ja) 1997-06-24
PT731811E (pt) 2005-04-29
JP3545408B2 (ja) 2004-07-21
EP0731811A1 (de) 1996-09-18
JP2004067698A (ja) 2004-03-04
US6113899A (en) 2000-09-05
EP0733071A1 (de) 1996-09-25
WO1995015338A1 (en) 1995-06-08
AU684578B2 (en) 1997-12-18
JP3987104B2 (ja) 2007-10-03
CA2177179C (en) 2006-10-17
US6417334B1 (en) 2002-07-09
AU1103695A (en) 1995-06-19
DE69434137T2 (de) 2005-12-01
EP0731811B1 (de) 2004-11-17
AU684577B2 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
ATE282634T1 (de) Chaperonin 10
DE69838143D1 (de) Antimikrobielle peptide
NZ333999A (en) GnRH-leukotoxin chimeric proteins for use in vaccines
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
CA2143491A1 (en) A novel peptide related to human programmed cell death and dna encoding it
ATE355074T1 (de) Hybrid aus interferon-alpha und immunglobulin fc- fragment verbunden durch ein nicht immunogenes peptid
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
CA2290485A1 (en) Method for the production of non-immunogenic proteins
GB9108652D0 (en) Immunoreactive compounds
YU49126B (sh) Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina
DE69926627D1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
ATE395361T1 (de) Das h-y antigen
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
CA2163805A1 (en) Novel activating factor of leukocytes
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
WO2001070774B1 (en) Human t cell response to mhc-binding motif clusters
SE0002738D0 (sv) Electric actuator
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
WO2000026240A3 (en) Streptococcal alpha2m-binding protein
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties